Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
30 January, 2015 01:52 IST
Dr Reddys gets USFDA nod for Sildenafil tablets
Source: IRIS | 19 Nov, 2012, 09.43AM
Comments  |  Post Comment

Dr Reddys Laboratories, an integrated global pharmaceutical company,  announced that it has launched Sildenafil tablets (20 mg), a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

It has received approval by the United States Food & Drugs Administration (USFDA) for ANDA Sildenafil tablets.

The Revatio brand had US sales of approximately USD 338.67 million for the most recent 12 months ending September 2012 according to IMS health.

Shares of the company gained Rs 16, or 0.91%, to trade at Rs 1,773.35. The total volume of shares traded was 755 at the BSE (9.32 a.m., Monday).



Dr Reddy`S Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
HDFC Sec upgrades Pidilite Industries to 'Buy' - 29-Jan-2015 18:30
FIIs can invest up to 100% in Veritas: RBI - 29-Jan-2015 18:20
Trent standalone quarterly net drops 31.75% - 29-Jan-2015 18:13
Oudh Sugar Mills loss narrows in Oct-Dec quarter - 29-Jan-2015 18:07
Grindwell Norton consolidated quarterly net up 35.11% - 29-Jan-2015 17:58
Kotak Mahindra Bank to invest 19.9% in Airtel M Commerce Services - 29-Jan-2015 17:56
Kotak Mahindra Bank to invest 19.9% in Airtel M Commerce Services - 29-Jan-2015 17:56
Essel Propack consolidated quarterly earnings climb 7.38% - 29-Jan-2015 17:51
Shriram City Union Finance standalone quarterly earnings rise 10.73% - 29-Jan-2015 17:47
Tata Teleservices (Maharashtra) loss widens in Oct-Dec quarter - 29-Jan-2015 17:41
Hikal standalone quarterly net falls 8.85% - 29-Jan-2015 17:15
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer